Protagenic Therapeutics gets FDA pre-IND feedback for PT00114
Protagenic Therapeutics says the FDA provided pre-IND feedback supporting a new IND for PT00114 in generalized anxiety disorder.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.